Relationship of hepatocellular carcinoma to soya food consumption: A cohort-based, case-control study in Japan

International Journal of Cancer

Volumn 115, Issue 2, 2005, Pages 290-295

  Sharp, Gerald B ^a,b,e   Lagarde, Frederic ^a,b   Mizuno, Terumi ^a   Sauvaget, Catherine ^a,b   Fukuhara, Toshiyuki ^c   Allen, Naomi ^d   Suzuki, Gen ^a   Tokuoka, Shoji ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NATIONAL ACADEMY OF SCIENCES   (United States)

^c HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Hepatitis b virus; Hepatitis c virus; Hepatocellular carcinoma; Isoflavone; Soya

Indexed keywords

ARTICLE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD INTAKE; HEPATITIS B; HUMAN; JAPAN; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SOYBEAN; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; FOOD HABITS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; JAPAN; LIVER NEOPLASMS; RISK FACTORS; SOY FOODS;

EID: 17844370846     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20897     Document Type: Article

References (46)

1. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-54.
2. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, Hsiao TJ, Lin SM, Lee SD, Chen PJ, Liu CJ, Chen CJ. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2000;92:2023-8.
3. Tanaka K, Sakai H, Hashizume M, Hirohata T. Serum testosterone: estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res 2000;60:5106-10.
4. Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C. Female hormone utilisation and risk of hepatocellular carcinoma. Br J Cancer 1993;67:635-7.
5. Trichopoulos D. Etiology of primary liver cancer and the role of steroidal hormones. Cancer Causes Control 1992;3:3-5.
6. Mucci LA, Kuper HE, Tamimi R, Lagiou P, Spanos E, Trichopoulos D. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG 2001;108:291-4.
7. Peelers PH, Keinan-Boker L, van der Schouw YT, Grobbee DE, eds. Phytoestrogens and breast cancer risk: review of the epidemiological evidence. IARC Sci Publ 156. Lyon: IARC, 2002;331-6.
8. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 2002;132:3168-71.
9. L downregulation, and Cdc2 kinase activity. Nutr Cancer 2003;45:113-23.
10. Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y, Takahashi A, Tsukamoto T, et al. A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci 2004;95:238-42.
11. Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, Gao YT, Shu XO. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 2004;328:1285-9.
12. Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2002;83:113-18.
13. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991;337:1197-200.
14. Lei B, Roncaglia V, Vigano R, Cremonini C, De Maria N, Del Buono MG, Manenti F, Villa E. Phytoestrogens and liver disease. Mol Cell Endocrinol 2002;193:81-4.
15. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13. Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003;160:381-407.
16. Mabuchi K, Soda M, Ron E, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL, Thompson DE. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res 1994;137:S1-16.
17. Sharp GB, Cologne JB, Fukuhara T, Itakura H, Yamamoto M, Tokuoka S. Temporal changes in liver cancer incidence rates in Japan: accounting for death certificate inaccuracies and improving diagnostic techniques. Int J Cancer 2001;93:751-8.
18. Fukuhara T, Sharp GB, Mizuno T, Itakura H, Yamamoto M, Tokunaga M, Tokuoka S, Cologne JB, Fujita Y, Soda M, Mabuchi K. Liver cancer in atomic-bomb survivors: histological characteristics and relationships to radiation and hepatitis B and C viruses. J Radiat Res (Tokyo) 2001;42:117-30.
19. Gibson JB, Sobin LH. Histological typing of tumours of the liver, biliary tract and pancreas. International histological classification of tumours. Geneva: WHO, 1978.
20. Shikata T, Uzawa T, Yoshiwara N, Akatsuka T, Yamazaki S. Staining methods of Australia antigen in paraffin section-detection of cytoplasmic inclusion bodies. Jpn J Exp Med 1974;44:25-36.
21. Iwamoto KS, Mizuno T, Ito T, Akiyama M, Takeichi N, Mabuchi K, Seyama T. Feasibility of using decades-old archival tissues in molecular oncology/epidemiology. Am J Pathol 1996;149:399-406.
22. Mizuno T, Nagamura H, Iwamoto KS, Ito T, Fukuhara T, Tokunaga M, Tokuoka S, Mabuchi K, Seyama T. RNA from decades-old archival tissue blocks for retrospective studies. Diagn Mol Pathol 1998;7:202-8.
23. Sauvaget C, Allen N, Hayashi M, Spencer E, Nagano J. Validation of a food frequency questionnaire in the Hiroshima/Nagasaki Life Span Study. J Epidemiol 2002;12:394-401.
24. Goodman MT, Moriwaki H, Vaeth M, Akiba S, Hayabuchi H, Mabuchi K. Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology 1995;6:36-41.
25. Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osuga T, Aikawa T. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 1996;91:1195-203.
26. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
27. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7.
28. De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol 2002;193:59-63.
29. Vesselinovitch SD, Mihailovich N. The effect of gonadectomy on the development of hepatomas induced by urethane. Cancer Res 1967; 27:1788-91.
30. Chao Y, Chan WK, Huang YS, Teng HC, Wang SS, Lui WY, Whang-Peng J, Lee SD. Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 1996;77:635-9.
31. Grimaldi C, Bleiberg H, Gay F, Messner M, Rougier P, Kok TC, Cirera L, Cervantes A, De Greve J, Paillot B, Buset M, Nitti D, et al. Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial. J Clin Oncol 1998;16:411-417.
32. Farinati F, De Maria N, Marafin C, Fagiuoli S, Delia LG, Naccarato R. Hepatocellular carcinoma in alcoholic cirrhosis: is sex hormone imbalance a pathogenetic factor? Eur J Gastroenterol Hepatol 1995;7:145-50.
33. Nagasue N, Ogawa Y, Yukaya H, Ohta N, Ito A. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma. Gastroenterology 1985;88:768-72.
34. CLIP Group. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme). Lancet 1998;352:17-20.
35. Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993;15:790-4.
36. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, Chen CJ. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001;93:1644-51.
37. Villa E, Dugani A, Moles A, Camellini L, Grottola A, Buttafoco P, Merighi A, Ferretti I, Esposito P, Miglioli L, Bagni A, Troisi R, et al. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease. Hepatology 1998;27:983-8.
38. Hsing AW, Hoover RN, McLaughlin JK, Co-Chien HT, Wacholder S, Blot WJ, Fraumeni JF Jr. Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 1992;3:43-8.
39. Kumar NB, Cantor A, Allen K, Riccardi D, Cox CE. The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 2002;94:1166-74.
40. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40.
41. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000;27:67-73.
42. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18:4608-18.
43. Mokhtar NM, el Aaser AA, el Bolkainy MN, Ibrahim HA, el Din NB, Moharram NZ. Effect of soybean feeding on experimental carcinogenesis-III. Carcinogenicity of nitrite and dibutylamine in mice: a histopathological study. Eur J Cancer Clin Oncol 1988;24:403-11.
44. WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells. Int J Oncol 2001;18:997-1002.
45. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995;125:790S-7S.
46. Kang LP, Qi LH, Zhang JP, Shi N, Zhang M, Wu TM, Chen J. Effect of genistein and quercetin on proliferation, collagen synthesis, and type I procollagen mRNA levels of rat hepatic stellate cells. Acta Pharmacol Sin 2001;22:793-6.